Xiaodong Teng

3.0k total citations
116 papers, 1.7k citations indexed

About

Xiaodong Teng is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Xiaodong Teng has authored 116 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Oncology, 41 papers in Pulmonary and Respiratory Medicine and 33 papers in Molecular Biology. Recurrent topics in Xiaodong Teng's work include Renal cell carcinoma treatment (12 papers), Thyroid Cancer Diagnosis and Treatment (12 papers) and Renal and related cancers (10 papers). Xiaodong Teng is often cited by papers focused on Renal cell carcinoma treatment (12 papers), Thyroid Cancer Diagnosis and Treatment (12 papers) and Renal and related cancers (10 papers). Xiaodong Teng collaborates with scholars based in China, United States and United Kingdom. Xiaodong Teng's co-authors include Ming Zhao, Lisong Teng, Weibin Wang, Zhong‐Nan Yang, Jun Zhu, Yue Lou, Xianglei He, Haiyong Wang, Zhongqi Li and Wenhe Zhao and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Xiaodong Teng

108 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaodong Teng China 24 716 482 397 376 267 116 1.7k
Jinglin Cao China 20 489 0.7× 414 0.9× 214 0.5× 254 0.7× 148 0.6× 77 1.2k
Carsten Boltze Germany 29 750 1.0× 893 1.9× 532 1.3× 422 1.1× 174 0.7× 87 2.7k
Diane Kowalski United States 22 628 0.9× 351 0.7× 767 1.9× 559 1.5× 129 0.5× 45 2.0k
Ario Takeuchi Japan 24 765 1.1× 913 1.9× 512 1.3× 313 0.8× 212 0.8× 114 1.9k
Thea Kalebic United States 21 727 1.0× 314 0.7× 424 1.1× 82 0.2× 332 1.2× 60 1.6k
Junichi Inokuchi Japan 28 1.1k 1.5× 1.0k 2.1× 478 1.2× 401 1.1× 254 1.0× 161 2.4k
Haiyong Wang China 27 867 1.2× 370 0.8× 550 1.4× 327 0.9× 180 0.7× 83 1.8k
Sun Och Yoon South Korea 26 940 1.3× 369 0.8× 844 2.1× 409 1.1× 181 0.7× 132 2.5k
John H. Yim United States 30 684 1.0× 272 0.6× 1.0k 2.6× 539 1.4× 510 1.9× 79 2.6k
K Dohi Japan 16 528 0.7× 94 0.2× 380 1.0× 311 0.8× 305 1.1× 87 1.3k

Countries citing papers authored by Xiaodong Teng

Since Specialization
Citations

This map shows the geographic impact of Xiaodong Teng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaodong Teng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaodong Teng more than expected).

Fields of papers citing papers by Xiaodong Teng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaodong Teng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaodong Teng. The network helps show where Xiaodong Teng may publish in the future.

Co-authorship network of co-authors of Xiaodong Teng

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaodong Teng. A scholar is included among the top collaborators of Xiaodong Teng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaodong Teng. Xiaodong Teng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deng, Jingwen, Chen Li, Xiao Zhou, et al.. (2025). S100A2 promotes clear cell renal cell carcinoma tumor metastasis through regulating GLUT2 expression. Cell Death and Disease. 16(1). 135–135. 2 indexed citations
2.
Zhao, Ming, Xiaoqun Yang, Hualei Gan, et al.. (2024). ALK-Rearranged Renal Cell Carcinoma: A Multi-Institutional Study of 9 Cases With Expanding the Morphologic and Molecular Genetic Spectrum. Modern Pathology. 37(8). 100536–100536. 5 indexed citations
3.
Zhang, Jiuquan, Xiaodong Teng, Qi Lai, et al.. (2023). 1MO Image biomarker discovery from DCE-MRI for identifying responders of MK-2206 on early-stage breast cancer patients: A secondary radio-genomics analysis of I-SPY2 trial. Annals of Oncology. 34. S1468–S1468. 1 indexed citations
4.
Lai, Chong, Jinlong Tang, Qin Liu, et al.. (2023). SCGN and STAT3 expressions are associated with the prognosis of ccRCC. Pathology - Research and Practice. 252. 154940–154940. 3 indexed citations
5.
Zhou, Jie, Weiran Wang, Huifang Zhang, et al.. (2023). Molecular and clinical features of papillary thyroid cancer in adult patients with a non-classical phenotype. Frontiers in Endocrinology. 14. 1138100–1138100. 6 indexed citations
6.
Huang, Dongdong, Huifang Zhang, Lu Li, et al.. (2022). Proteotypic Differences of Follicular-Patterned Thyroid Neoplasms. Frontiers in Endocrinology. 13. 854611–854611. 8 indexed citations
7.
Wang, Zheng, Xiaoxi Wang, Fei Cheng, et al.. (2021). Rapamycin Inhibits Glioma Cells Growth and Promotes Autophagy by miR-26a-5p/DAPK1 Axis. Cancer Management and Research. Volume 13. 2691–2700. 21 indexed citations
8.
Sun, Qingrong, Siyi Chen, Yingjian Hou, et al.. (2021). Mutant CDKN2A regulates P16/p14 expression by alternative splicing in renal cell carcinoma metastasis. Pathology - Research and Practice. 223. 153453–153453. 8 indexed citations
9.
Wang, Xiaoling, Xiaodong Teng, Wei Ding, Ke Sun, & Bo Wang. (2020). A clinicopathological study of 30 breast cancer cases with a HER2/CEP17 ratio of ≥2.0 but an average HER2 copy number of <4.0 signals per cell. Modern Pathology. 33(8). 1557–1562. 8 indexed citations
10.
11.
Peng, Ling, Qiqi Mao, Bo Jiang, et al.. (2020). Bilateral Posterior Uveitis and Retinal Detachment During Immunotherapy: A Case Report and Literature Review. Frontiers in Oncology. 10. 549168–549168. 9 indexed citations
12.
Wu, Lingyan, Muhammad Saif Ur Rahman, Xiaodong Teng, et al.. (2019). Promoter Hypomethylation Is Responsible for Upregulated Expression of HAI-1 in Hepatocellular Carcinoma. Disease Markers. 2019. 1–12. 9 indexed citations
13.
Teng, Lisong, Xingyun Su, Xiaoxia Jiang, et al.. (2016). Diagnostic value of BRAFV600E-mutation analysis in fine-needle aspiration of thyroid nodules: a&nbsp;meta-analysis. OncoTargets and Therapy. 9. 2495–2495. 29 indexed citations
14.
Qiu, Yan, Shan Liu, Chaohui Yu, et al.. (2013). Upregulation of caveolin-1 and SR-B1 in mice with non-alcoholic fatty liver disease. Hepatobiliary & pancreatic diseases international. 12(6). 630–636. 39 indexed citations
15.
Jiang, Weiqin, Weibin Wang, Fangfang Fu, et al.. (2012). A more sensitive platform for the detection of low-abundance BRAFV600E mutations. Molecular and Cellular Biochemistry. 366(1-2). 49–58. 8 indexed citations
16.
Sun, Ke, et al.. (2011). Solitary fibrous tumor of the liver: a case report. World Journal of Surgical Oncology. 9(1). 37–37. 18 indexed citations
17.
Teng, Xiaodong, et al.. (2011). Factors associated with recurrence and therapeutic strategies for sinonasal rosai–dorfman disease. Head & Neck. 34(10). 1504–1513. 28 indexed citations
18.
Chen, Xinhua, et al.. (2009). Testicular choriocarcinoma metastatic to skin and multiple organs. Two case reports and review of literature. Journal of Cutaneous Pathology. 37(4). 486–490. 13 indexed citations
19.
Teng, Xiaodong & Qihan You. (2005). [Infiltrating myofibroblastoma of the breast in female: a case report].. PubMed. 34(3). 186–186. 3 indexed citations
20.
Teng, Xiaodong, et al.. (2004). [Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses].. PubMed. 33(3). 212–6. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinglin Cao Breakdown of academic impact, for papers by Carsten Boltze Breakdown of academic impact, for papers by Diane Kowalski Breakdown of academic impact, for papers by Ario Takeuchi Breakdown of academic impact, for papers by Thea Kalebic Breakdown of academic impact, for papers by Junichi Inokuchi Breakdown of academic impact, for papers by Haiyong Wang Breakdown of academic impact, for papers by Sun Och Yoon Breakdown of academic impact, for papers by John H. Yim Breakdown of academic impact, for papers by K Dohi
Rankless by CCL
2026